Completed NA INTERVENTIONAL 1-arm NCT01322737

Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System (SUMO)

Evaluation of a Novel Endoscopic Polypectomy Device in Excised Human Colon and Gastric Tissue.

Sponsor: Apollo Endosurgery, Inc.

Conditions Colon Disease Gastric Disease

Interventions Tissue Access and Resection System

Updated 5 times since 2017 Last updated: Dec 12, 2014 Started: Jan 31, 2011 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Colon Disease and Gastric Disease, this trial is completed. The trial is conducted by Apollo Endosurgery, Inc. and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Apollo Endosurgery, Inc.
University Hospitals Cleveland Medical Center

Data source: University Hospitals Cleveland Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States